Literature DB >> 21907862

Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study.

Andrea S Gershon1, Laura Warner, Paul Cascagnette, J Charles Victor, Teresa To.   

Abstract

BACKGROUND: Although chronic obstructive pulmonary disease (COPD) is one of the most deadly, prevalent, and costly chronic diseases, no comprehensive estimates of the risk of developing COPD in the general population have been published. We aimed to quantify the lifetime risk of developing physician-diagnosed COPD in a large, multicultural North American population.
METHODS: We did a retrospective longitudinal cohort study using population-based health administrative data from Ontario, Canada (total population roughly 13 million). All individuals free of COPD in 1996 were monitored for up to 14 years for three possible outcomes; diagnosis of COPD by a physician, reached 80 years of age, or death. COPD was identified with a previously validated case definition based on COPD health services claims. The cumulative incidence of physician-diagnosed COPD over a lifetime adjusted for the competing risk of death was calculated by a modified survival analysis technique. Results were stratified by sex, socioeconomic status, and whether individuals lived in a rural or urban setting.
FINDINGS: A total of 579,466 individuals were diagnosed with COPD by a physician over the study period. The overall lifetime risk of physician-diagnosed COPD at age 80 years was 27·6%. Lifetime risk was higher in men than in women (29·7%vs 25·6%), individuals of lower socioeconomic status than in those of higher socioeconomic status (32·1%vs 23·0%), and individuals who lived in a rural setting than in those who lived in an urban setting (32·4%vs 26·7%).
INTERPRETATION: About one in four individuals are likely to be diagnosed and receive medical attention for COPD during their lifetime. Clinical evidence-based approaches, public health action, and more research are needed to identify effective strategies to prevent COPD and ensure that those with the disease have the highest quality of life possible. FUNDING: Government of Ontario, Canada.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21907862     DOI: 10.1016/S0140-6736(11)60990-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  91 in total

1.  Patterns of Pulmonary Consultation for Veterans with Incident Chronic Obstructive Pulmonary Disease.

Authors:  Eduardo R Nunez; Shelsey W Johnson; Shirley X Qian; W Ryan Powell; Allan J Walkey; Renda Soylemez Wiener; Seppo T Rinne
Journal:  Ann Am Thorac Soc       Date:  2021-07

2.  Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA.

Authors:  Gurinder Singh; Amitesh Agarwal; Wei Zhang; Yong-Fang Kuo; Rizwana Sultana; Gulshan Sharma
Journal:  Sleep Breath       Date:  2018-06-22       Impact factor: 2.816

Review 3.  The matrikine PGP as a potential biomarker in COPD.

Authors:  Mojtaba Abdul Roda; Amanda M Fernstrand; Frank A Redegeld; J Edwin Blalock; Amit Gaggar; Gert Folkerts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-10       Impact factor: 5.464

4.  Rural and urban married Asian immigrants in Taiwan: determinants of their physical and mental health.

Authors:  Walter Chen; Wen-Been Shiao; Blossom Yen-Ju Lin; Cheng-Chieh Lin
Journal:  J Immigr Minor Health       Date:  2013-12

5.  Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use.

Authors:  Hans Petersen; Akshay Sood; Paula M Meek; Xian Shen; Yan Cheng; Steven A Belinsky; Caroline A Owen; George Washko; Victor Pinto-Plata; Emer Kelly; Bartolome Celli; Yohannes Tesfaigzi
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

6.  Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.

Authors:  Martin Söderholm; Malin Inghammar; Bo Hedblad; Arne Egesten; Gunnar Engström
Journal:  Eur J Epidemiol       Date:  2015-12-28       Impact factor: 8.082

Review 7.  Airway inflammation in chronic obstructive pulmonary disease.

Authors:  Nikolaos Angelis; Konstantinos Porpodis; Paul Zarogoulidis; Dionysios Spyratos; Ioannis Kioumis; Antonis Papaiwannou; Georgia Pitsiou; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Theodora Tsiouda; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Machairiotis; Michael Argyriou; George Kessisis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

8.  Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).

Authors:  Basit Ahmad; Nina Ferrari; Georgina Montiel; Wilhelm Bloch; Anke Raabe-Oetker; Nina Skrobala; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2013-02-20

9.  The burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in Canada.

Authors:  M Reza Maleki-Yazdi; Suzanne M Kelly; S Ys Lam; Mihaela Marin; Martin Barbeau; Valery Walker
Journal:  Can Respir J       Date:  2012 Sep-Oct       Impact factor: 2.409

10.  Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.

Authors:  William A Fischer; Michael B Drummond; Christian A Merlo; David L Thomas; Robert Brown; Shruti H Mehta; Robert A Wise; Greg D Kirk
Journal:  COPD       Date:  2013-07-17       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.